Skip to content
Star Health Insurance logo

Star Health Insurance

Star Health & Allied Insurance Company Ltd

STARHEALTH NSE
₹556.05 −12.60 (−2.22%)
Market Cap
₹32,730 Cr
P/E
31.05
View as Markdown
MCP
Close 20 Nov 2026 ₹556.05 1Y +59.15 +11.9%
Start ₹496.90

Key Fundamentals

SmallcapInsuranceFinancial Services

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
9.69%
Debt to Equity
0.01
EPS (TTM)
₹17.91
Book Value
₹177.29
Market Cap
₹32,730 Cr
P/E (TTM)
31.05
P/B
3.14
ROE
7.61%
Dividend Yield
0.00%
EBITDA
₹834 Cr
52W High
₹624.90
52W Low
₹416.55
Day Range
₹553.40 – ₹566.00
Volume
2,64,371

Peer Comparison

Financial Services › Insurance › General Insurance

Star Health Insurance peer comparison
1,736.0033.9086,7334.610.43%16.60%21.90%29,0382,555
332.306.5058,2990.793.91%14.60%17.40%54,9938,969
Star Health Insurance (this company)
556.0531.0532,7303.140.00%7.61%9.69%20,0561,054
152.63—25,1530.891.00%4.92%4.29%50,234−528
239.0027.2522,1112.720.00%12.20%13.10%11,994810
74.3639.7613,7543.580.00%3.46%3.15%8,905345
Median 6 companies285.6531.0528,9422.930.22%9.91%11.40%24,547932

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

44 Weak

Data confidence 97/100

Category scores

Quality
47
Average
Returns, margins, earnings quality 22% weight
Valuation
47
Average
Cheap vs sector & own history 24% weight
Growth
50
Average
Sales & profit trajectory 9% weight
Financial Health
33
Poor
Solvency, leverage, coverage 9% weight
Momentum
62
Good
Trend strength, vol-adjusted 12% weight
Ownership
34
Poor
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company has reduced debt.
  • Company is almost debt free.

Weaknesses

3
  • Stock is trading at 3.14 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 10.2% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish379
OscillatorsBullish072
Moving AveragesStrong Bullish307

Key readings

RSI (14)
51.36
Neutral
MACD (12,26,9)
4.66
Bullish
SMA (50)
548.83
Bullish
SMA (200)
531.33
Bullish

As of

Analyst Rating

Based on 18 analysts
BUY89%

16 of 18 analysts rate Buy, 1 Hold, 1 Sell.

As of

BUY
16
89%
HOLD
1
6%
SELL
1
6%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+27.30%
5Y+28.69%
3Y+13.80%
1Y+10.71%
TTM+13.51%

Net profit

Net profit growth by window
10Y+15.06%
5YTurned to profit
3Y−3.46%
1Y−13.78%
TTM+43.60%

Operating cash flow

Operating cash flow growth by window
10Y—
5Y+16.05%
3Y+13.65%
1Y+35.82%
TTM—

10Y: The statements do not go back far enough for this window.

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−5.16 pp
5Y+32.28 pp
3Y−2.60 pp
1Y−1.10 pp
TTM+1.58 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹2,012 Cr
Mar 2018₹2,888 Cr
Mar 2019₹3,775 Cr
Mar 2020₹4,987 Cr
Mar 2021₹5,050 Cr
Mar 2022₹10,602 Cr
Mar 2023₹12,096 Cr
Mar 2024₹14,021 Cr
Mar 2025₹16,101 Cr
Mar 2026₹17,825 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹118 Cr
Mar 2018₹170 Cr
Mar 2019₹128 Cr
Mar 2020₹268 Cr
Mar 2021−₹1,086 Cr
Mar 2022−₹1,041 Cr
Mar 2023₹619 Cr
Mar 2024₹845 Cr
Mar 2025₹646 Cr
Mar 2026₹557 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EPS
₹5.11 +13.6% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 19 Nov 2026
AI opinion · based on fundamentals
Risk medium

Star Health & Allied Insurance, trading at ₹568.65 as of 2026-11-19 with a market cap of ₹33,472 Cr, is a virtually debt-free standalone health insurer that has delivered strong long-term sales growth of 27% CAGR over 10 years and a TTM profit growth of 44%, but trades at a P/E of 31.75x and P/B of 3.21x with no dividend payout and a modest ROE of 7.35%.

Bull Case 7
  • TTM profit growth of 44% signals a sharp earnings recovery, suggesting improving underwriting discipline or favourable claims experience
  • 10-year compounded sales growth of 27% demonstrates a sustained ability to scale in India's underpenetrated health insurance market
  • The company is virtually debt-free with a debt-to-equity ratio of just 0.06, providing financial flexibility and low balance-sheet risk
  • 5-year compounded profit growth of 20% indicates the business has been able to translate top-line expansion into bottom-line gains over a meaningful period
  • Median sales growth of 21% over the last 10 years reflects consistent revenue compounding rather than lumpy or one-off growth
  • The stock is trading roughly 9% below its 52-week high of ₹624.90, having recovered significantly from its 52-week low of ₹416.55 — a 36.5% move off the bottom
  • 1-year stock CAGR of 12% shows the market has begun to re-rate the company following the earnings upturn
Bear Case 7
  • 3-year compounded profit growth is negative at -3%, indicating the recent earnings surge follows a period of profit contraction
  • Despite reporting consistent profits, the company pays zero dividend (yield 0%), offering no income return to shareholders
  • P/B ratio of 3.21x is elevated for a company generating an ROE of just 7.35%, implying the stock price embeds expectations well above current return on capital
  • 3-year ROE averages only about 10% and the latest annual ROE stands at 7.35%, which is modest relative to the valuation premium
  • ROCE is reported at -9.4%, raising questions about the efficiency of total capital employed in the business
  • 3-year stock CAGR of 0% means investors who bought three years ago have earned no capital appreciation, despite the business growing sales at 14% CAGR over the same period
  • TTM sales growth of 14% represents a deceleration from the 5-year compounded sales growth of 29%, suggesting the top-line momentum may be slowing

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

23h ago

TL;DR: Star Health is delivering strong earnings momentum with Q2FY27 PAT up 233% YoY and a healthy combined ratio of 91.97%, while attracting institutional interest via HDFC MF's approved stake increase to 9.99%. The ₹2 crore IRDAI penalty is a minor regulatory blemish with no material operational impact. The trend is improving on profitability and institutional ownership, and sustained underwriting discipline will be key to watch in upcoming quarters.

Headwinds 1
  • IRDAI penalty for claim violations Nov 20

    IRDAI imposed a ₹2 crore penalty on Star Health for claim settlement violations identified during an early 2022 inspection. The company states no operational impact beyond the monetary fine.

Positives 2
  • Q2FY27 PAT surges 233% YoY Oct 27

    Star Health reported ₹26,481 lakh net profit for Q2FY27, up 233% YoY. Insurance revenue rose 15.4% to ₹507 crore and combined operating ratio improved to 91.97%.

  • HDFC MF approved for 9.99% stake Nov 9

    IRDAI approved HDFC Mutual Fund's acquisition of up to 9.99% equity in Star Health, including its existing 4.49% holding. Institutional interest signals confidence in the insurer.

Neutral 2
  • Promoter group reclassification sought Oct 30

    Star Health applied to exchanges to reclassify promoter group entities as public shareholders under SEBI LODR Regulation 31A(8)(c).

  • Analyst and investor meets scheduled Nov 11

    Star Health scheduled one-on-one analyst meetings on Nov 3 covering Q2 FY27 performance, and a group analyst meet on Nov 16 at an annual investor conference in Mumbai.

Quarterly Results

₹ Cr
STARHEALTH quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
3,461
3,578
3,688
3,816
4,058
4,146
4,081
4,880
4,561
4,566
4,648
5,500
5,341
Expenses
3,296
3,191
3,502
3,391
3,912
3,861
4,089
4,292
4,448
4,395
4,500
4,751
4,984
Operating Profit
165
387
186
425
147
285
−7
588
113
172
148
749
358
OPM %
4.8%
11%
5%
11%
3.6%
7%
−0.2%
12%
2.5%
3.8%
3.2%
14%
7%
Other Income
2
1
3
1
2
2
6
0
−1
2
4
−8
−6
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
167
388
190
426
149
287
−1
588
112
173
151
742
352
Tax %
25%
25%
25%
25%
25%
25%
−159%
25%
29%
26%
26%
26%
25%
Net Profit
125
290
142
319
111
215
1
438
80
128
111
550
265
EPS (₹)
2.15
4.95
2.43
5.45
1.89
3.66
0.01
7.45
1.35
2.18
1.89
9.34
4.50
YoY Sales growth
15
16
18
16
17
16
11
28
12
10
14
13
17

Profit & Loss

₹ Cr
STARHEALTH profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1,069
1,595
2,012
2,888
3,775
4,987
5,050
10,602
12,096
14,021
16,101
17,825
20,056
Expenses
1,189
1,439
1,871
2,673
3,565
4,544
6,447
11,962
11,223
12,840
15,180
17,001
18,630
Operating Profit
−120
156
141
215
210
443
−1,397
−1,360
873
1,182
921
824
1,426
OPM %
−11%
10%
7%
7%
6%
9%
−28%
−13%
7%
8%
6%
4.6%
7%
Other Income
0
0
0
0
0
0
−3
7
5
6
12
9
−8
Interest
1
2
3
20
0
0
0
0
0
0
0
0
0
Depreciation
19
18
20
23
28
29
46
43
52
59
71
79
0
PBT
−140
137
118
171
182
413
−1,446
−1,397
826
1,129
861
754
1,418
Tax %
0%
0%
0%
1%
30%
35%
−25%
−25%
25%
25%
25%
26%
—
Net Profit
−140
137
118
170
128
268
−1,086
−1,041
619
845
646
557
1,054
EPS (₹)
−2.53
2.47
2.13
3.08
2.32
4.84
−19.62
−18.08
10.63
14.44
10.99
9.47
17.91
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Sales growth
—
49
26
44
31
32
1
110
14
16
15
11
14

Balance Sheet

₹ Cr
STARHEALTH balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
362
387
456
456
456
491
548
576
582
585
588
588
589
Reserves
−220
−27
334
504
773
1,153
2,947
4,045
4,862
5,799
6,471
6,987
9,847
Borrowings
0
0
0
250
250
250
250
720
470
470
470
470
76
Other Liabilities
954
1,012
1,423
2,138
3,394
4,233
6,756
8,174
9,313
10,914
13,255
16,019
13,781
Total Liabilities
1,096
1,372
2,213
3,347
4,872
6,127
10,501
13,514
15,226
17,768
20,785
24,064
24,293
Fixed Assets
46
62
77
92
85
90
183
113
217
159
357
404
312
CWIP
12
3
7
5
13
12
19
4
10
16
24
9
0
Investments
502
807
1,428
2,165
3,030
4,290
6,733
11,373
13,276
15,491
17,703
19,780
22,491
Other Assets
535
500
700
1,085
1,744
1,735
3,565
2,024
1,723
2,102
2,701
3,871
1,490
Total Assets
1,096
1,372
2,213
3,347
4,872
6,127
10,501
13,514
15,226
17,768
20,785
24,064
24,293

Cash Flow

₹ Cr
STARHEALTH cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
—
321
557
776
647
890
56
1,276
1,310
1,379
1,873
Investing
—
—
−497
−663
−731
−1,006
−2,418
−3,786
−1,097
−1,177
−1,151
−1,067
Financing
—
—
310
249
333
122
2,613
2,509
−268
23
−4
−31
Net Cash Flow
—
—
134
143
379
−237
1,086
−1,221
−89
156
224
775
Free Cash Flow
—
—
283
521
746
614
844
−7
1,229
1,187
1,297
1,797
CFO/EBITDA
—
—
228
260
397
168
−70
−4
145
119
170
250

Ratios

STARHEALTH financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
0
0
0
0
0
0
0
0
0
0
0
0
Cash Conversion Cycle
0
0
0
0
0
0
0
0
0
0
0
0
Working Capital Days
−255
−179
−191
−196
−260
−238
−397
−258
−255
−249
−261
−286
ROCE %
—
55%
21%
19%
14%
25%
−51%
−31%
15%
18%
12%
10%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Star Health Insurance insights

36 extracted metrics across FY15–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 58.00%
  • DIIs 18.77%
  • FIIs 15.85%
  • Public 4.39%
  • Others 2.98%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Star Health Insurance

What does Star Health & Allied Insurance Company Ltd do?
Star Health & Allied Insurance Ltd (Star) is India’s first Standalone Health Insurance provider and is the largest private health insurer in India with a market share of 15.8% in the Indian health insurance market in FY21 with leadership in the attractive retail health segment.
Where is Star Health & Allied Insurance Company Ltd (STARHEALTH) listed?
Star Health & Allied Insurance Company Ltd trades as STARHEALTH on the NSE and under code 543412 on the BSE.
Which sector does Star Health & Allied Insurance Company Ltd belong to?
Star Health & Allied Insurance Company Ltd is classified under the Financial Services sector, in the Insurance industry.
What is the market capitalisation of Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd has a market capitalisation of ₹32,730 Cr as of 20 Nov 2026, which places it in the Smallcap band.
What is the PE ratio of Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd trades at a PE ratio of 31.05 as of 20 Nov 2026, on earnings per share of ₹17.91, against a book value of ₹177.29 per share.
What is the 52-week high and low of Star Health & Allied Insurance Company Ltd?
Over the last 52 weeks Star Health & Allied Insurance Company Ltd has traded between ₹416.55 and ₹624.9 as of 20 Nov 2026.
What is the Return on Equity (ROE) of Star Health & Allied Insurance Company Ltd?
Star Health & Allied Insurance Company Ltd reported a return on equity of 7.61%. Its debt-to-equity ratio is 0.01.

Company Information

Star Health & Allied Insurance Ltd (Star) is India’s first Standalone Health Insurance provider and is the largest private health insurer in India with a market share of 15.8% in the Indian health insurance market in FY21 with leadership in the attractive retail health segment.

Listed 10 Dec 2021
Face Value ₹10
Shares Outstanding 58,86,23,619

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/STARHEALTH.md for Star Health & Allied Insurance Company Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More